Chevron Left
医薬品開発 に戻る

カリフォルニア大学サンディエゴ校 による 医薬品開発 の受講者のレビューおよびフィードバック

4.7
2,024件の評価

コースについて

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Development course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug development. In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), New Drug Application (NDA), and product labeling. Additionally you will learn how to Incorporate study design methods for consideration in the design of clinical protocols to assess safety, tolerability, and efficacy in multiple therapeutic areas. In this course you will learn the different phases of clinical development: * Phase 1 or early stage clinical trial are conducted primar­ily to determine how the new drug works in humans, its safety profile and to predict its dosage range. It typically involves between 30 and 100 healthy volunteers. * Phase 2 or Proof of Concept POC studies test for efficacy as well as safety and side effects in a group of between 30 to 200 hundred patients with the disease for which the new drug is being developed. * Phase 3 or late stage clinical development involve much larger group of patients, between a few hundred to thousands, depending on the indication, which will help determine if the new drug can be considered both safe and effective. It will involve control groups using placebo and/or current treatment as a comparison. * Product registration and approval process after a drug is considered safe and effective from Phase 3 trials, it must be authorized in each individual country before it can be marketed. All data gen­erated about the small molecule or biologic is collected and submitted to the regulatory authorities in the US at the FDA, Food and Drug Administration FDA, in Europe the EMA or European Medicines Agency, Japan Ministry of Health and other countries which may require their own national approvals. This course is intended as part 2 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development and Drug Commercialization (https://www.coursera.org/learn/drug-commercialization). We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place....

人気のレビュー

HG

2018年10月15日

Very well done and informative. I truly appreciate the Drug process in entirety being broken down into sections that are easy to comprehend. It is obvious the speakers were chosen for their knowledge.

KR

2020年5月24日

I am really glad to have course offered by california university . Its really helpful for me. And i am thankful to all lecturer, and teachers to explain overall drug development process.

Thank you!

フィルター:

医薬品開発: 126 - 150 / 410 レビュー

by Abburu S

2020年5月23日

by Felipe R F

2020年1月19日

by Imani

2020年7月31日

by Rohan M

2020年4月23日

by Penugonda V L D S S

2020年5月28日

by Chinmay P

2020年7月29日

by Sahil K

2020年8月14日

by SNEHA V

2020年8月8日

by Ansumita B

2020年5月5日

by David L

2019年10月29日

by Maria T

2022年3月29日

by Reem M A R

2020年6月28日

by Yashwantsinh J

2020年6月18日

by Prateek K

2021年10月1日

by CHANCHALA A

2020年6月27日

by KONKEPUDI G M

2020年6月15日

by H C

2017年8月6日

by Mohammed M H C

2020年4月18日

by t. O

2019年3月14日

by Arshad s

2019年3月10日

by Ahmed

2020年9月21日

by DEVIS M M D P

2020年9月17日

by Nancy Z

2021年2月1日

by NALLIPOGU S T

2020年9月29日

by Talissa C M D B

2020年7月28日